[Elsevier] LANCET Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes |
|
This post will be closed automatically in 2026-08-03 19:36
Best Answer
Yesterday 19:37
|
| |
| |
post
reply
points
1965
10
Uranium concentration from acidic mine effluent using forward osmosis
10
Sleep-Disordered Breathing in Hospitalized Patients
10
Interface modification of membrane substrates: Mitigating microbial interfacial adhesion and augmenting adsorptive capacity for seawater uranium recovery
10
Better Together
10
A Blueprint for Success
